DOI QR코드

DOI QR Code

Glycosylation of Semi-Synthetic Isoflavene Phenoxodiol with a Recombinant Glycosyltransferase from Micromonospora echinospora ATCC 27932

  • Seo, Minsuk (Transdisciplinary Major in Learning Health Systems, Department of Integrated Biomedical and Life Sciences, Korea University) ;
  • Seol, Yurin (Transdisciplinary Major in Learning Health Systems, Department of Integrated Biomedical and Life Sciences, Korea University) ;
  • Park, Je Won (Department of Integrated Biomedical and Life Sciences, Korea University)
  • Received : 2021.11.18
  • Accepted : 2022.02.05
  • Published : 2022.05.28

Abstract

Glycosyltransferase (GT)-specific degenerate PCR screening followed by in silico sequence analyses of the target clone was used to isolate a member of family1 GT-encoding genes from the established fosmid libraries of soil actinomycetes Micromonospora echinospora ATCC 27932. A recombinant MeUGT1 was heterologously expressed as a His-tagged protein in E. coli, and its enzymatic reaction with semi-synthetic phenoxodiol isoflavene (as a glycosyl acceptor) and uridine diphosphate-glucose (as a glycosyl donor) created two different glycol-attached products, thus revealing that MeUGT1 functions as an isoflavonoid glycosyltransferase with regional flexibility. Chromatographic separation of product glycosides followed by the instrumental analyses, clearly confirmed these previously unprecedented glycosides as phenoxodiol-4'-α-O-glucoside and phenoxodiol-7-α-O-glucoside, respectively. The antioxidant activities of the above glycosides are almost the same as that of parental phenoxodiol, whereas their anti-proliferative activities are all superior to that of cisplatin (the most common platinum chemotherapy drug) against two human carcinoma cells, ovarian SKOV-3 and prostate DU-145. In addition, they are more water-soluble than their parental aglycone, as well as remaining intractable to the simulated in vitro digestion test, hence demonstrating the pharmacological potential for the enhanced bio-accessibility of phenoxodiol glycosides. This is the first report on the microbial enzymatic biosynthesis of phenoxodiol glucosides.

Keywords

Acknowledgement

This work was supported by Korea University Grant (K1808551).

References

  1. Kapoor B, Gulati M, Gupta R, Singh SK, Gupta M, Nabi A, et al. 2021. A review on plant flavonoids as potential anticancer agents. Curr. Org. Chem. 25: 737-747. https://doi.org/10.2174/1385272824999201126214150
  2. Ahmed QU, Ali AHM, Mukhtar S, Alsharif MA, Parveen H, Sabere ASM, et al. 2020. Medicinal potential of isoflavonoids: polyphenols that may cure diabetes. Molecules 25: 5491. https://doi.org/10.3390/molecules25235491
  3. Wen KM, Fang XC, Yang JL, Yao YF, Nandakumar KS, Salem ML, et al. 2021. Recent research on flavonoids and their biomedical applications. Curr. Med. Chem. 28: 1042-1066. https://doi.org/10.2174/0929867327666200713184138
  4. Alshehri MM, Sharifi-Rad J, Herrera-Bravo J, Jara EL, Salazar LA, Kregiel D, et al. 2021. Therapeutic potential of isoflavones with an emphasis on daidzein. Oxid. Med. Cell Longev. 2021: 6331630.
  5. Javed Z, Khan K, Herrera-Bravo J, Naeem S, Iqbal MJ, Sadia H, et al. 2021. Genistein as a regulator of signaling pathways and microRNAs in different types of cancers. Cancer Cell Int. 21: 388. https://doi.org/10.1186/s12935-021-02091-8
  6. Tang H, Wang S, Li X, Zou T, Huang X, Zhang W, et al. 2019. Prospects of and limitations to the clinical applications of genistein. Discov. Med. 27: 177-188.
  7. Fatima A, Khan MS, Ahmad MW. 2020. Therapeutic potential of equol: a comprehensive review. Curr. Pharm. Des. 26: 5837-5843. https://doi.org/10.2174/1381612826999201117122915
  8. Porter K, Fairlie WD, Laczka O, Delebecque F, Wilkinson J. 2020. Idronoxil as an anticancer agent: activity and mechanisms. Curr. Cancer Drug Targets 20: 341-354. https://doi.org/10.2174/1568009620666200102122830
  9. Milke L, Aschenbrenner J, Marienhagen J, Kallscheuer N. 2018. Production of plant-derived polyphenols in microorganisms: current state and perspectives. Appl. Microbiol. Biotechnol. 102: 1575-1585. https://doi.org/10.1007/s00253-018-8747-5
  10. Song MC, Kim EJ, Kim E, Rathwell K, Nam SJ, Yoon YJ. 2014. Microbial biosynthesis of medicinally important plant secondary metabolites. Nat. Prod. Rep. 31: 1497-1509. https://doi.org/10.1039/C4NP00057A
  11. Xiao J, Muzashvili TS, Georgiev MI. 2014. Advances in the biotechnological glycosylation of valuable flavonoids. Biotechnol. Adv. 32: 1145-1156. https://doi.org/10.1016/j.biotechadv.2014.04.006
  12. Ji Y, Li B, Qiao M, Li J, Xu H, Zhang L, Zhang X. 2020. Advances on the in vivo and in vitro glycosylations of flavonoids. Appl. Microbiol. Biotechnol. 104: 6587-6600. https://doi.org/10.1007/s00253-020-10667-z
  13. Xiao JB. 2017. Dietary flavonoid aglycones and their glycosides: which show better biological significance? Crit. Rev. Food Sci. Nutr. 57: 1874-1905.
  14. Yee EM, Pasquier E, Iskander G, Wood K, Black DS, Kumar N. 2013. Synthesis of novel isoflavene-propranolol hybrids as anti-tumor agents. Bioorg. Med. Chem. 21: 1652-1660. https://doi.org/10.1016/j.bmc.2013.01.059
  15. Yee EMH, Brandl MB, Black DS, Vittorio O, Kumar N. 2017. Synthesis of isoflavene-thiosemicarbazone hybrids and evaluation of their anti-tumor activity. Bioorg. Med. Chem. Lett. 27: 2454-2458. https://doi.org/10.1016/j.bmcl.2017.04.002
  16. Hoang NH, Hong SY, Huong NL, Park JW. 2016. Biochemical characterization of recombinant UDP-glucose: sterol 3-O-glycosyltransferase from Micromonospora rhodorangea ATCC 31603 and enzymatic biosynthesis of sterol-3-O-b-glucosides. J. Microbiol. Biotechnol. 26: 477-482. https://doi.org/10.4014/jmb.1511.11003
  17. Hoang NH, Huong NL, Kim B, Park JW. 2016. Kinetic studies on recombinant UDP-glucose: sterol 3-O-β-glycosyltransferase from Micromonospora rhodorangea and its bioconversion potential. AMB Express 6: 52. https://doi.org/10.1186/s13568-016-0224-x
  18. Shrestha A, Pandey RP, Dhakal D, Parajuli P, Sohng JK. 2018. Biosynthesis of flavone C-glucosides in engineered Escherichia coli. Appl. Microbiol. Biotechnol. 102: 1251-1267. https://doi.org/10.1007/s00253-017-8694-6
  19. Chen YS, Ma X, Fu X, Yan R. 2017. Phytochemical content, cellular antioxidant activity and antiproliferative activity of Adinandra nitida tea (Shiyacha) infusion subjected to in vitro gastrointestinal digestion. RSC Adv. 7: 50430-50440. https://doi.org/10.1039/C7RA07429H
  20. Bashyal P, Thapa SB, Kim TS, Pandey RP, Sohng JK. 2020. Exploring the nucleophilic N- and S-glycosylation capacity of Bacillus licheniformis YjiC enzyme. J. Microbiol. Biotechnol. 30: 1092-1096. https://doi.org/10.4014/jmb.2001.01024
  21. Liu B, Zhao C, Xiang Q, Zhao N, Luo Y, Bao R. 2021. Structural and biochemical studies of the glycosyltransferase Bs-YjiC from Bacillus subtilis. Int. J. Biol. Macromol. 166: 806-817. https://doi.org/10.1016/j.ijbiomac.2020.10.238
  22. Murota K, Nakamura Y, Uehara M. 2018. Flavonoid metabolism: the interaction of metabolites and gut microbiota. Biosci. Biotechnol. Biochem. 82: 600-610. https://doi.org/10.1080/09168451.2018.1444467